Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37881150)

  • 1. Identification of angiogenesis-related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer.
    Wang F; Wang C; Li B; Wang G; Meng Z; Han J; Guo G; Yu B; Wang G
    Biotechnol Appl Biochem; 2024 Feb; 71(1):45-60. PubMed ID: 37881150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma.
    Cui G; Liu J; Wang M; Shon K; Wang C; Wei F; Sun Z
    Front Immunol; 2022; 13():1049485. PubMed ID: 36505481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.
    Jiang HZ; Yang B; Jiang YL; Liu X; Chen DL; Long FX; Yang Z; Tang DX
    Front Oncol; 2022; 12():1025397. PubMed ID: 36387195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer.
    Ji Y; Ge Q; Zhang W; Qu P
    Reprod Sci; 2023 May; 30(5):1637-1650. PubMed ID: 36471217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
    Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
    PeerJ; 2023; 11():e16477. PubMed ID: 38025763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
    Wang Z; Niu D
    Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
    Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
    Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy.
    Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y
    Front Genet; 2022; 13():975404. PubMed ID: 36699444
    [No Abstract]   [Full Text] [Related]  

  • 15. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
    Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
    Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
    Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
    Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroptosis is related to immune infiltration and predictive for survival of colon adenocarcinoma patients.
    Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
    Sci Rep; 2022 Jun; 12(1):9233. PubMed ID: 35655081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer.
    Zeng C; He R; Dai Y; Lu X; Deng L; Zhu Q; Liu Y; Liu Q; Lu W; Wang Y; Jin J
    Front Pharmacol; 2022; 13():1069204. PubMed ID: 36467074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.